The field of viral diseases continues to pose significant challenges to global health. With the emergence of new viruses and the re-emergence of old ones, traditional methods of prevention and control often fall short. The complexity of viral mechanisms, high mutation rates, and resistance to existing treatments underscore the need for innovative strategies in combating these formidable pathogens. Recent studies have highlighted the importance of integrating new scientific approaches into the development of antivirals and vaccines, while also improving delivery systems to enhance their efficacy and accessibility.
Several groundbreaking studies have provided evidence that advances in molecular biology, immunology, and biotechnology hold promise in revolutionizing the way we prevent and control viral diseases. For instance, the advent of mRNA vaccines and their successful application in managing COVID-19 have opened new pathways for rapid vaccine development. Similarly, novel antiviral agents targeting specific viral proteins have shown effectiveness in reducing viral load and mitigating disease severity. Despite these advances, there remain significant gaps in adaptability across different viral families and long-term efficacy, prompting ongoing research to optimize these strategies.
This Research Topic aims to explore and highlight innovative strategies for the prevention and control of viral diseases, focusing on the development of advanced antivirals, novel vaccines, and effective delivery systems. By addressing the limitations of current approaches, the research seeks to contribute to more comprehensive prevention and treatment methods, thereby enhancing global health security. Key objectives include the evaluation of emerging vaccine platforms, the formulation of broad-spectrum antivirals, and the advancement of targeted delivery technologies to improve therapeutic outcomes.
To gather further insights into viral disease mitigation strategies, we welcome articles addressing, but not limited to, the following themes:
1. Advances in mRNA, vector-based, and protein subunit vaccines 2. Development of broad-spectrum and targeted antivirals 3. Innovations in drug delivery systems, including nanoparticles and microneedles 4. Strategies to overcome viral resistance and improve immune response 5. Integration of biotechnology tools in viral pathogen tracking and surveillance
We encourage submissions that span a range of article types, including original research, reviews, and case studies, to foster a comprehensive discourse on the topic.
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Clinical Trial
Data Report
Editorial
FAIR² Data
General Commentary
Hypothesis and Theory
Methods
Mini Review
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Article types
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Clinical Trial
Data Report
Editorial
FAIR² Data
General Commentary
Hypothesis and Theory
Methods
Mini Review
Opinion
Original Research
Perspective
Policy and Practice Reviews
Policy Brief
Review
Study Protocol
Systematic Review
Technology and Code
Keywords: Innovative Vaccine Platforms, Broad-Spectrum Antivirals, Advanced Delivery Systems, Viral Resistance and Immune Response, Biotechnology in Surveillance
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
